Enzymatic determination of HBA1c
AssigneeDiaSys Diagnostic Systems GmbH
InventorsGünther Gorka, Yoshifumi Watazu, Erwin Metzmann, Alexandra Lein, Holger Müller, Matthias Grimmler
Life of this patent
Estimating the term…
Loading patent…
AssigneeDiaSys Diagnostic Systems GmbH
InventorsGünther Gorka, Yoshifumi Watazu, Erwin Metzmann, Alexandra Lein, Holger Müller, Matthias Grimmler
Estimating the term…
A method for determining the amount of glycated haemoglobin (HbA1c), in which—if required—the erythrocytes in a sample are haemolysed, the haemoglobin that is then released—if required—is contacted with a proteolytic agent and the glycated haemoglobin degradation products obtained in this way or otherwise are quantified is disclosed. In order to provide such a process and reagents employable therein that has/have the property of sufficient stability of the chemical compounds that are essential to the reaction, for the stabilization of the haemoglobin which is unfolded at a very low pH in the range from 1 to 3, at least one suitable stabilizer is present in the haemolysis solution. Where a leuco dye is used in connection with the determination of the amount of HbA1c, it is proposed that the latter be stabilized with particular phosphine compounds and/or thio compounds, and, in particular embodiments, the requisite proteolytic agent is to be provided in the form of an inactivated protease which is then only reactivated in situ.
A method of determining the amount of glycated haemoglobin (HbA1c) in a sample, wherein the following method steps are performed:
A reagent kit for use in a method of determining the amount of glycated haemoglobin (HbA1c) in a sample, wherein the reagent kit includes at least the following solutions in separate containers:
Dependencies are inferred from the claim text.